BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 06, 2010
 |  BC Week In Review  |  Company News  |  Deals

Nostrum, Institute of Microbial Technology deal

Nostrum received an exclusive, worldwide license from the institute to develop and commercialize second-generation thrombolytics for indications including heart attack and stroke. Nostrum will develop single bolus...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >